Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 543
5
Diseases
21
Unique genes
0.107
Avg. similarity score
Distal muscular dystrophy
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Distal muscular dystrophy
Distal myopathy
Distal axonal motor neuropathy-myofibrillar myopathy syndrome
Distal myopathy with vocal cord weakness
Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Distal muscular dystrophy | 4 | 4 | 7 |
| Distal myopathy | 4 | 4 | 19 |
| Distal axonal motor neuropathy-myofibrillar myopathy syndrome | 2 | 2 | 1 |
| Distal myopathy with vocal cord weakness | 2 | 2 | 1 |
| Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HNRNPA1 | 3 / 5 | Distal muscular dystrophy, Distal myopathy, Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 |
| HSPB8 | 3 / 5 | Distal axonal motor neuropathy-myofibrillar myopathy syndrome, Distal muscular dystrophy, Distal myopathy |
| MATR3 | 3 / 5 | Distal muscular dystrophy, Distal myopathy, Distal myopathy with vocal cord weakness |
| MYH7 | 2 / 5 | Distal muscular dystrophy, Distal myopathy |
| TTN | 2 / 5 | Distal muscular dystrophy, Distal myopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cytoskeleton in muscle cells | KEGG | 6 / 232 | 14.8× | 2.07e-6 | 7.79e-5 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 3 / 99 | 17.3× | 6.49e-4 | 8.17e-3 ✓ sig. |
| Dilated cardiomyopathy | KEGG | 3 / 105 | 16.3× | 7.70e-4 | 9.29e-3 ✓ sig. |
| FGFR2 alternative splicing | Reactome | 2 / 26 | 44.0× | 9.23e-4 | 1.07e-2 ✓ sig. |
| Smooth Muscle Contraction | Reactome | 2 / 34 | 33.6× | 1.58e-3 | 1.60e-2 ✓ sig. |
| Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2 | Reactome | 1 / 1 | 572× | 1.75e-3 | 1.73e-2 ✓ sig. |
| Striated Muscle Contraction | Reactome | 2 / 36 | 31.8× | 1.77e-3 | 1.74e-2 ✓ sig. |
| Amyotrophic lateral sclerosis | KEGG | 4 / 368 | 6.2× | 3.43e-3 | 2.80e-2 ✓ sig. |
| Viral myocarditis | KEGG | 2 / 70 | 16.3× | 6.55e-3 | 4.35e-2 ✓ sig. |
| Mitophagy - animal | KEGG | 2 / 105 | 10.9× | 1.43e-2 | 7.05e-2 |
| Pexophagy | Reactome | 1 / 10 | 57.2× | 1.74e-2 | 7.88e-2 |
| HSF1 activation | Reactome | 1 / 12 | 47.7× | 2.08e-2 | 8.77e-2 |
| Purine ribonucleoside monophosphate biosynthesis | Reactome | 1 / 12 | 47.7× | 2.08e-2 | 8.77e-2 |
| Cell-extracellular matrix interactions | Reactome | 1 / 12 | 47.7× | 2.08e-2 | 8.77e-2 |
| Caspase-mediated cleavage of cytoskeletal proteins | Reactome | 1 / 12 | 47.7× | 2.08e-2 | 8.77e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| sarcomere organization | GO:0045214 | 3 / 43 | 62.1× | 1.47e-5 | 7.31e-4 ✓ sig. |
| detection of muscle stretch | GO:0035995 | 2 / 7 | 254× | 2.52e-5 | 1.10e-3 ✓ sig. |
| visual perception | GO:0007601 | 4 / 215 | 16.6× | 8.75e-5 | 2.80e-3 ✓ sig. |
| cardiac muscle hypertrophy | GO:0003300 | 2 / 13 | 137× | 9.31e-5 | 2.93e-3 ✓ sig. |
| muscle filament sliding | GO:0030049 | 2 / 15 | 119× | 1.25e-4 | 3.63e-3 ✓ sig. |
| detection of light stimulus involved in visual perception | GO:0050908 | 2 / 24 | 74.2× | 3.27e-4 | 7.13e-3 ✓ sig. |
| striated muscle contraction | GO:0006941 | 2 / 24 | 74.2× | 3.27e-4 | 7.13e-3 ✓ sig. |
| cardiac muscle cell development | GO:0055013 | 2 / 25 | 71.2× | 3.55e-4 | 7.57e-3 ✓ sig. |
| regulation of calcium ion transport | GO:0051924 | 2 / 25 | 71.2× | 3.55e-4 | 7.57e-3 ✓ sig. |
| positive regulation of ubiquitin-dependent protein catabolic process | GO:2000060 | 2 / 30 | 59.3× | 5.13e-4 | 9.67e-3 ✓ sig. |
| skeletal muscle contraction | GO:0003009 | 2 / 32 | 55.6× | 5.85e-4 | 1.06e-2 ✓ sig. |
| ATP metabolic process | GO:0046034 | 2 / 36 | 49.4× | 7.41e-4 | 1.23e-2 ✓ sig. |
| regulation of heart rate | GO:0002027 | 2 / 39 | 45.6× | 8.69e-4 | 1.34e-2 ✓ sig. |
| cardiac muscle contraction | GO:0060048 | 2 / 43 | 41.4× | 1.06e-3 | 1.51e-2 ✓ sig. |
| response to low light intensity stimulus | GO:0009645 | 1 / 1 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Distal muscular dystrophy | Distal myopathy | 0.227 | 5 | 3.29e-14 | 3.83e-13 ✓ sig. |
| Distal axonal motor neuropathy-myofibrillar myopathy syndrome | Distal muscular dystrophy | 0.125 | 1 | 4.52e-4 | 8.26e-4 ✓ sig. |
| Distal muscular dystrophy | Distal myopathy with vocal cord weakness | 0.125 | 1 | 4.52e-4 | 8.26e-4 ✓ sig. |
| Distal muscular dystrophy | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 0.125 | 1 | 4.52e-4 | 8.26e-4 ✓ sig. |
| Distal axonal motor neuropathy-myofibrillar myopathy syndrome | Distal myopathy | 0.050 | 1 | 1.23e-3 | 1.81e-3 ✓ sig. |
| Distal myopathy | Distal myopathy with vocal cord weakness | 0.050 | 1 | 1.23e-3 | 1.81e-3 ✓ sig. |
| Distal myopathy | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 0.050 | 1 | 1.23e-3 | 1.81e-3 ✓ sig. |